You just read:

HSRx Group In-Licenses Portfolio of Novel Late-Stage Orphan and Breakthrough Combination Drugs, Acquires Ready-for-Market OTC Drugs

News provided by

HSRx Group

05 Aug, 2015, 19:33 BST